Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Ending Cash Position : $409 Mil (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Aspen Pharmacare Holdings Ending Cash Position?

Aspen Pharmacare Holdings's Ending Cash Position for the quarter that ended in Dec. 2023 was $409 Mil.

Aspen Pharmacare Holdings's quarterly Ending Cash Position increased from Dec. 2022 ($308 Mil) to Jun. 2023 ($400 Mil) and increased from Jun. 2023 ($400 Mil) to Dec. 2023 ($409 Mil).

Aspen Pharmacare Holdings's annual Ending Cash Position declined from Jun. 2021 ($428 Mil) to Jun. 2022 ($314 Mil) but then increased from Jun. 2022 ($314 Mil) to Jun. 2023 ($400 Mil).

Aspen Pharmacare Holdings Ending Cash Position Historical Data

The historical data trend for Aspen Pharmacare Holdings's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspen Pharmacare Holdings Ending Cash Position Chart

Aspen Pharmacare Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Ending Cash Position

Get a 7-Day Free Trial

421.53

327.82

428.01

314.33

399.74

Aspen Pharmacare Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															345.21	314.33	307.58	399.74	408.96

Aspen Pharmacare Holdings Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Aspen Pharmacare Holdings's Ending Cash Position for the fiscal year that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	265.194	+	134.544
	=	400

Aspen Pharmacare Holdings's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	402.14	+	6.816
	=	409

Aspen Pharmacare Holdings Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Aspen Pharmacare Holdings's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aspen Pharmacare Holdings Ltd (OTCPK:APNHF) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

APN:South Africa APNHY:USA

Address

Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF

Website

https://www.aspenpharma.com

Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) - this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin - this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Headlines

From GuruFocus

Value Idea Contest: Aspen Pharmacare

By Matthew Sipos Matthew Sipos • 03-17-2019

Aspiring for Aspen Pharmacare Holdings Ltd's Dividend: A Comprehensive Analysis

By GuruFocus Research • 09-21-2023